Corteva Announces Board of Directors for Advanced Seed and Genetics Spin-Off Vylor

Corporate Action
โดย PR Newswire·Read original
Summary · why it matters

Corteva has named the board of directors for Vylor, the advanced seed and genetics company it plans to spin off in the fourth quarter of 2026. Karen Grimes, a current Corteva director and former senior managing director at Wellington Management, will serve as independent chair of the seven-member board. The board also includes Victor Aguilar of Procter & Gamble, Rajesh Kalathur formerly of Deere & Company, Marcos Lutz formerly of Ultrapar Participações, future Vylor CEO Chuck Magro, Johannes Oosthuizen of Merck, and Kerry Preete formerly of Monsanto. A search is underway for at least one additional director. Vylor will focus on elite germplasm, gene editing, and molecular breeding, and plans to expand its licensing business and potentially move into new row crops.

Impact on stocks 8

Synthetic Biology (non-pharma)▲ · 1 stocks
Corteva Inc
CTVA
± MixedCapitalrelevance

Corteva is spinning off Vylor, a structural change that may unlock value but also reduces Corteva's scope.

Health Care▲ · 1 stocks
Climate Adaptation & Water▲ · 1 stocks
Quantum Computing▲ · 1 stocks
Biotech & Genomic Medicine▲ · 1 stocks
Critical Materials & Supply Chain▲ · 1 stocks
Consumer Staples▲ · 1 stocks
Energy▲ · 1 stocks

Off-coverage companies 2

Vylor Inc.Private▲ Positive
Capitalrelevance

Vylor is being established as a standalone advanced seed and genetics company with a strong board and strategic focus.

Wellington Management CompanyPrivate± Mixed
relevance

© 2026 MarketDXNews